You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Antibody in asthma treatment- and explain in detail?
Ans. is 'a' i.e., OmalizumabOmalizumabo Omalizumab is an anti IgE agent approved by the (FDA) for use in patients age 12 and above with moderate to severe persistent allergic asthma with : -An IgE level of30-700 lu/ml.Positive allergen skin or specific IgE tests to a perenmial allergen andIncomplete symptom control with inhaled glucocorticoid treatment.o Omalizumab is administered by "subcutaneous injection " every mo to four weeks in a dose that is determined by- body weights and the level of serum IgE.o Omalizumab produces 25% reduction in rate of asthma exacerbations.o The response to omalizumab therapy is variable and difficult to predict with overall response rates in patients with moderate to severe asthma averaging 30-50%.o A minimum of 12 weeks of treatment is necessary to determine the efficacy1 ofanti-IgE therapy.